Roche/Genentech and AstraZeneca have the best-performing medical science liaison (MSL) teams in oncology, according to a ZoomRx survey of physicians. | Roche/Genentech and AstraZeneca have the best-performing medical science liaison (MSL) teams in oncology, according to a ZoomRx survey of physicians.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Doximity inks partnerships with Aledade, Photon as it ramps up AI spending in 2026
EU and US advisers split over AstraZeneca breast cancer drug
Agentforce Life Sciences Now Used by More Than 140 Industry-Leading Organizations to Unify Health Engagement and Boost Outcomes
Turn Language Access into an Operational Advantage
Eli Lilly tops prominent rankings on pharma R&D performance
AstraZeneca picks up FDA approval for hypertension drug
A new ranking of pharma companies by R&D performance
AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
Merck & Co. and Kelun-Biotech's sac-TMT is on fire this week with details or first reports of three positive phase 3 trials. |…
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
With the help of DNA testing company Natera and its personalized molecular residual disease (MRD) blood test Signatera, Roche’s…
Doceree has bold ambitions to bring a new software category to pharma brand teams, one that reshapes campaign deployment in the…
Doximity plans to accelerate its spending on artificial intelligence this year as it aims to become a leading AI platform for…
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating early detection of lung cancer.
